Company intelligence / Profile preview

Biogenera SpA

Ozzano dell'Emilia, Emilia-Romagna, Italybiogenera.com ↗

Ownership: Private
Development stage: Phase 1

Overview

Biogenera SpA develops patient-specific, DNA-based biotechnological medicines using its proprietary MyGenera™ platform. The lead candidate, BGA002, targets pediatric neuroblastoma and soft tissue sarcomas and has received Orphan Drug status from the European Medicines Agency. Preclinical studies show promise against aggressive adult cancers as well. The company collaborates with academic institutions such as the University of Bologna to expand its pipeline of gene-targeted therapies for oncology and other severe diseases with high unmet needs.

Therapeutic areas: Oncology
Modalities: DNA-based therapeutics (gene-specific oligonucleotides)
Industry: Biotech

Drug pipeline

8 assets

BGA003

Preclinical

7 more assets in the full pipeline.

Request access →

Partnerships

Collaborations with universities including University of BolognaPartnerships with pharmaceutical companies (not specifically named)

Beyond the preview

Go deeper on Biogenera SpA.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Biogenera SpA.

Explore the full profile